5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.42▲ | 3.41▲ | 3.40▲ | 3.30▲ | 4.11▼ |
MA10 | 3.39▲ | 3.37▲ | 3.39▲ | 3.71▼ | 3.62▼ |
MA20 | 3.38▲ | 3.38▲ | 3.31▲ | 4.12▼ | 2.07▲ |
MA50 | 3.37▲ | 3.25▲ | 3.43▼ | 3.23▲ | 1.24▲ |
MA100 | 3.28▲ | 3.52▼ | 4.03▼ | 1.88▲ | 15.00▼ |
MA200 | 3.23▲ | 4.14▼ | 3.31▲ | 1.25▲ | 217.73▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | 0.000▲ | 0.031▲ | -0.203▼ | 0.292▲ |
RSI | 54.422▲ | 56.822▲ | 54.410▲ | 41.781▼ | 58.854▲ |
STOCH | 93.927▲ | 60.456 | 34.794 | 14.468▼ | 70.587 |
WILL %R | -13.793▲ | -62.687 | -50.602 | -77.143▼ | -43.640 |
CCI | 88.860 | 47.789 | 72.828 | -64.124 | 25.630 |
▼ RSI&MOM | $VIVE Oversold + Momentum Rising | Set Alert |
Thursday, January 21, 2021 06:04 AM
Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it has initiated its multicenter, randomized, double-blinded, sham-controlled trial entitled ...
|
Wednesday, January 20, 2021 01:46 AM
Tax Planning Personal Finance Save for College Save for Retirement Invest in Retirement Research Mutual Funds Stocks ETFs Bonds Best Investments ...
|
Tuesday, January 19, 2021 02:29 PM
(MENAFN - ACCESSWIRE) ENGLEWOOD, CO / ACCESSWIRE / January 19, 2021 / Viveve Medical, Inc. ( & quot;Viveve & quot;) (NASDAQ:VIVE), a medical technology company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/01/21 | 3.46 | 3.46 | 3.26 | 3.43 | 2,195,701 |
21/01/21 | 3.35 | 3.65 | 3.25 | 3.46 | 7,231,782 |
20/01/21 | 3.23 | 3.3899 | 3.14 | 3.25 | 3,912,045 |
19/01/21 | 3.20 | 3.21 | 3.10 | 3.19 | 2,121,755 |
15/01/21 | 3.26 | 3.26 | 3.10 | 3.17 | 2,171,769 |
14/01/21 | 3.05 | 3.25 | 3.03 | 3.18 | 10,949,265 |
13/01/21 | 4.03 | 4.14 | 4.00 | 4.00 | 909,179 |
12/01/21 | 4.40 | 4.45 | 3.9525 | 4.19 | 1,104,819 |
11/01/21 | 4.67 | 4.70 | 4.40 | 4.51 | 225,554 |
08/01/21 | 4.54 | 4.78 | 4.45 | 4.68 | 168,536 |
|
|
||||
|
|
||||
|
|